Home » 20: Phase II trial of ivonescimab in patients with advanced clear cell renal cell carcinoma previously treated with immune checkpoint blockade: IVORY trial (NCT06940518) – PMC
20: Phase II trial of ivonescimab in patients with advanced clear cell renal cell carcinoma previously treated with immune checkpoint blockade: IVORY trial (NCT06940518) – PMC
by Nazli Dizman, Rebecca S Slack-Tidwell, Rahul A Sheth, Omar Alhalabi, Matthew T Campbell, Paul G Corn, Sangeeta Goswami, Andrew Johns, Eric Jonasch, John K Lin, Amishi Y Shah, Jianbo Wang, Amado J Zurita-Saavedra, Jianjun Gao, Nizar Tannir, Andrew W Hahn & Pavlos Msaouel | Oct 10, 2025 | Articles |
